BiosparQ B.V. is a privately-held company dedicated to providing a unique in vitro diagnostics solution for rapid microbial identification called DigiTOF®. DigiTOF® improves patient outcomes, lowers healthcare costs and reduces prescription of antibiotics through enabling clinicians to speed up diagnosis of infections dramatically. The DigiTOF® system is a platform intended for the rapid and cost-effective detection and identification of infectious pathogens direct from patient material. DigiTOF® is based on MALDI-TOF Mass Spectrometry applied on single bacteria isolated directly from patient material. Ease of use, turnaround time of less than 20 minutes and low cost per test will ensure a large variety of applications.
BiosparQ B.V. is a privately-held company dedicated to providing a unique in vitro diagnostics solution for rapid microbial identification called DigiTOF®. DigiTOF® improves patient outcomes, lowers healthcare costs and reduces prescription of antibiotics through enabling clinicians to speed up diagnosis of infections dramatically. The DigiTOF® system is a platform intended for the rapid and cost-effective detection and identification of infectious pathogens direct from patient material. DigiTOF® is based on MALDI-TOF Mass Spectrometry applied on single bacteria isolated directly from patient material. Ease of use, turnaround time of less than 20 minutes and low cost per test will ensure a large variety of applications.